Important Patient-Level Recall: Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200 ml
Swissmedic issues a patient-centric recall for specific batches of Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200
Swissmedic issues a patient-centric recall for specific batches of Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200
Clinical research is advancing for patients recovering from subacute strokes. A study sponsored by Istituti Clinici Scientifici Maugeri SpA investigates
The FDA has announced a Class I recall for Baxter’s Life2000 Ventilation System, citing serious potential risks tied to cybersecurity
The FDA has flagged a critical recall concerning Balt USA’s Mega Ballast Distal Access Platform devices, identified as carrying a
In a significant step toward global regulatory alignment, Health Canada has announced it is adopting the International Medical Device Regulators
Between 10 and 14 November 2025, significant Field Safety Notices (FSNs) were announced, carrying potential implications for stakeholders across clinical,
On November 24, 2025, NYU Langone Health announced a pioneering clinical trial focused on a 3D-printed ingestible pill designed to
A new clinical trial is set to compare the efficacy and safety of a novel medical device, X92001919, with Paranix
On November 24, 2025, a new retrospective cohort study focusing on childhood, adolescent, and young adult cancers (CAYA) was announced.
On November 22, 2025, the FDA released details regarding a significant recall of the i-View Video Laryngoscope, manufactured by Intersurgical